NCT04405583 - The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

October 31, 2027

Conditions

Heart Failure

Interventions

DEVICE

Occlutech Atrial Flow Regulator

The Occlutech Atrial Flow Regulator is an interatrial shunt device for transcatheter delivery.

Trial Locations (14)

NOT_YET_RECRUITING

CHU Besançon, Besançon

RECRUITING

CHU Lyon, Lyon

RECRUITING

CHU Montpellier, Montpellier

NOT_YET_RECRUITING

Knappschaftskrankenhaus Bottrop GmbH, Bottrop

RECRUITING

Clinic Coburg, Coburg

RECRUITING

University Clinic, Cologne

ACTIVE_NOT_RECRUITING

Helios Clinic Erfurt, Erfurt

ACTIVE_NOT_RECRUITING

Cardiologicum Hamburg, Hamburg

RECRUITING

WKK Heide, Heide

RECRUITING

University Clinic Jena, Jena

RECRUITING

Clinic Osnabrück, Osnabrück

RECRUITING

Hospital Osnabrueck, Osnabrück

RECRUITING

Elbe Clinic Stade, Stade

ACTIVE_NOT_RECRUITING

University Clinic Tübingen, Tübingen